Published in Arch Intern Med on May 10, 2010
Recent progress in pancreatic cancer. CA Cancer J Clin (2013) 2.88
Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells. Cancer Lett (2011) 2.24
Hyperglycemia, insulin resistance, impaired pancreatic β-cell function, and risk of pancreatic cancer. J Natl Cancer Inst (2013) 1.80
Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression. Cancer Res (2011) 1.80
Genetic susceptibility to pancreatic cancer. Mol Carcinog (2012) 1.36
An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population. PLoS One (2013) 1.33
The complexities of obesity and diabetes with the development and progression of pancreatic cancer. Biochim Biophys Acta (2010) 1.29
Different patterns of Akt and ERK feedback activation in response to rapamycin, active-site mTOR inhibitors and metformin in pancreatic cancer cells. PLoS One (2013) 1.29
Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms. Mol Carcinog (2012) 1.26
A prospective analysis of telomere length and pancreatic cancer in the alpha-tocopherol beta-carotene cancer (ATBC) prevention study. Int J Cancer (2013) 1.22
Identifying people at a high risk of developing pancreatic cancer. Nat Rev Cancer (2012) 1.21
Excess body weight and obesity--the link with gastrointestinal and hepatobiliary cancer. Nat Rev Gastroenterol Hepatol (2011) 1.18
Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Cancer Causes Control (2012) 1.17
A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice. Gastroenterology (2013) 1.15
An anthropometric analysis of facial height, arch length, and palatal rugae in the Indian and Nepalese population. J Forensic Dent Sci (2011) 1.15
Prediagnostic body mass index and pancreatic cancer survival. J Clin Oncol (2013) 1.08
High-fat, high-calorie diet promotes early pancreatic neoplasia in the conditional KrasG12D mouse model. Cancer Prev Res (Phila) (2013) 1.08
Metformin inhibits the growth of human pancreatic cancer xenografts. Pancreas (2013) 1.05
Lifetime adiposity and risk of pancreatic cancer in the NIH-AARP Diet and Health Study cohort. Am J Clin Nutr (2013) 1.01
Hypoxia-induced aggressiveness of pancreatic cancer cells is due to increased expression of VEGF, IL-6 and miR-21, which can be attenuated by CDF treatment. PLoS One (2012) 0.98
Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: a pilot study. J Pain Symptom Manage (2012) 0.96
Epidemiology of pancreatic cancer and the role of family history. J Surg Oncol (2012) 0.94
Mechanistic target of rapamycin (mTOR): a point of convergence in the action of insulin/IGF-1 and G protein-coupled receptor agonists in pancreatic cancer cells. Front Physiol (2014) 0.93
A U-shaped relationship between plasma folate and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Eur J Cancer (2011) 0.93
Diabetes, pancreatic cancer, and metformin therapy. Front Physiol (2014) 0.92
Association of body mass index and risk of death from pancreas cancer in Asians: findings from the Asia Cohort Consortium. Eur J Cancer Prev (2013) 0.91
Association between allergies and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev (2014) 0.89
Reproductive factors, exogenous hormones, and pancreatic cancer risk in the CTS. Am J Epidemiol (2013) 0.89
Obesity and survival in population-based patients with pancreatic cancer in the San Francisco Bay Area. Cancer Causes Control (2012) 0.88
Risk factors and therapeutic targets in pancreatic cancer. Front Oncol (2013) 0.88
Body mass index and body size in early adulthood and risk of pancreatic cancer in a central European multicenter case-control study. Int J Cancer (2011) 0.88
Association between variations in the fat mass and obesity-associated gene and pancreatic cancer risk: a case-control study in Japan. BMC Cancer (2013) 0.86
Transcriptome analysis of pancreatic cancer reveals a tumor suppressor function for HNF1A. Carcinogenesis (2014) 0.85
Diabetes and pancreatic cancer. Minerva Gastroenterol Dietol (2012) 0.85
Exploring the metabolic syndrome: Nonalcoholic fatty pancreas disease. World J Gastroenterol (2016) 0.83
Rare long-term survivors of pancreatic adenocarcinoma without curative resection. World J Gastroenterol (2015) 0.82
Influence of Body Mass Index and Albumin on Perioperative Morbidity and Clinical Outcomes in Resected Pancreatic Adenocarcinoma. PLoS One (2016) 0.82
Serum lipid profiles and cancer risk in the context of obesity: four meta-analyses. J Cancer Epidemiol (2013) 0.81
Effect of Body Mass Index on Overall Survival of Pancreatic Cancer: A Meta-Analysis. Medicine (Baltimore) (2016) 0.81
Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters. World J Gastroenterol (2015) 0.79
Body mass index and risk of pancreatic cancer in a Chinese population. PLoS One (2014) 0.79
Establishing a clinic-based pancreatic cancer and periampullary tumour research registry in Quebec. Curr Oncol (2015) 0.79
E-cadherin expression in obesity-associated, Kras-initiated pancreatic ductal adenocarcinoma in mice. Surgery (2015) 0.79
A pooled analysis of body mass index and pancreatic cancer mortality in african americans. Cancer Epidemiol Biomarkers Prev (2014) 0.78
Whole Grain Intake Reduces Pancreatic Cancer Risk: A Meta-Analysis of Observational Studies. Medicine (Baltimore) (2016) 0.78
Association between vitamin C intake and the risk of pancreatic cancer: a meta-analysis of observational studies. Sci Rep (2015) 0.77
Association between alcohol consumption and pancreatic cancer risk: a case-control study. PLoS One (2015) 0.77
Global Trends in Pancreatic Cancer Mortality From 1980 Through 2013 and Predictions for 2017. Clin Gastroenterol Hepatol (2016) 0.76
A resequence analysis of genomic loci on chromosomes 1q32.1, 5p15.33, and 13q22.1 associated with pancreatic cancer risk. Pancreas (2013) 0.76
Risk Factors for Early-Onset and Very-Early-Onset Pancreatic Adenocarcinoma: A Pancreatic Cancer Case-Control Consortium (PanC4) Analysis. Pancreas (2016) 0.76
Insulin Receptor and GPCR Crosstalk Stimulates YAP via PI3K and PKD in Pancreatic Cancer Cells. Mol Cancer Res (2017) 0.75
Body Size Indicators and Risk of Gallbladder Cancer: Pooled Analysis of Individual-Level Data from 19 Prospective Cohort Studies. Cancer Epidemiol Biomarkers Prev (2017) 0.75
Diet and Pancreatic Cancer Prevention. Cancers (Basel) (2015) 0.75
Association between selenium intake and the risk of pancreatic cancer: a meta-analysis of observational studies. Biosci Rep (2016) 0.75
Serum Insulin-Like Growth Factor Axis and the Risk of Pancreatic Cancer: Systematic Review and Meta-Analysis. Nutrients (2017) 0.75
Development and Validation of a Prediction Model to Estimate Individual Risk of Pancreatic Cancer. PLoS One (2016) 0.75
Statins and pancreatic cancer. Oncol Lett (2017) 0.75
Association of cholesterol with risk of pancreatic cancer: a meta-analysis. World J Gastroenterol (2015) 0.75
Dietary total antioxidant capacity and pancreatic cancer risk: an Italian case-control study. Br J Cancer (2016) 0.75
Pancreatic Cancer: A Survival Analysis Study in Oklahoma. J Okla State Med Assoc (2016) 0.75
Central adiposity, obesity during early adulthood, and pancreatic cancer mortality in a pooled analysis of cohort studies. Ann Oncol (2015) 0.75
Pancreatic cancer risk in relation to sex, lifestyle factors, and pre-diagnostic anthropometry in the Malmö Diet and Cancer Study. Biol Sex Differ (2016) 0.75
Overweight increases the risk of malignancy in patients with pancreatic mucinous cystic neoplasms. Medicine (Baltimore) (2015) 0.75
Clinical significance of serum omentin-1 levels in patients with pancreatic adenocarcinoma. BBA Clin (2016) 0.75
Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy. Mol Cancer Ther (2016) 0.75
Self-Reported Questionnaire Detects Family History of Cancer in a Pancreatic Cancer Screening Program. J Genet Couns (2016) 0.75
The Clinical Implications of Fatty Pancreas: A Concise Review. Dig Dis Sci (2017) 0.75
Incidence of pancreatic cancer is dramatically increased by a high fat, high calorie diet in KrasG12D mice. PLoS One (2017) 0.75
Evolving treatment landscape for early and advanced pancreatic cancer. World J Gastrointest Oncol (2017) 0.75
Histone deacetylases, microRNA and leptin crosstalk in pancreatic cancer. World J Clin Oncol (2017) 0.75
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med (2003) 35.39
Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials (1998) 20.39
Pancreatic cancer. Lancet (2004) 11.63
European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr (2002) 8.77
Prospective study of alcohol consumption and risk of coronary disease in men. Lancet (1991) 8.64
Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst (2005) 8.36
The Nurses' Health Study: lifestyle and health among women. Nat Rev Cancer (2005) 8.19
The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group. Ann Epidemiol (1994) 6.47
The Shanghai Women's Health Study: rationale, study design, and baseline characteristics. Am J Epidemiol (2005) 6.44
The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Control Clin Trials (2000) 6.17
The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. Cancer (2002) 4.88
Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA (2001) 4.30
A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst (1995) 4.29
Abnormal glucose metabolism and pancreatic cancer mortality. JAMA (2000) 4.01
Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA (2009) 3.86
Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control (2006) 2.64
Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study. J Clin Oncol (2005) 2.51
Dietary patterns and their correlates among middle-aged and elderly Chinese men: a report from the Shanghai Men's Health Study. Br J Nutr (2007) 2.35
Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria. Br J Cancer (2005) 2.33
A prospective study of pancreatic cancer in the elderly. Int J Cancer (1994) 2.25
Obesity, recreational physical activity, and risk of pancreatic cancer in a large U.S. Cohort. Cancer Epidemiol Biomarkers Prev (2005) 2.16
Selection, follow-up, and analysis in the American Cancer Society prospective studies. Natl Cancer Inst Monogr (1985) 2.10
Lack of association of physical activity and obesity with incident pancreatic cancer in elderly women. Cancer Epidemiol Biomarkers Prev (2005) 1.92
Obesity and risk of cancer in Japan. Int J Cancer (2005) 1.79
Overall obesity, abdominal adiposity, diabetes and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population-based cohorts. Br J Cancer (2005) 1.71
Insulin promotes pancreatic cancer: evidence for endocrine influence on exocrine pancreatic tumors. J Surg Res (1996) 1.69
Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. Am J Epidemiol (2003) 1.45
Nucleotide excision repair pathway polymorphisms and pancreatic cancer risk: evidence for role of MMS19L. Cancer Epidemiol Biomarkers Prev (2009) 1.43
The insulin-pancreatic acinar axis. Diabetes (1985) 1.42
Body mass index and physical activity as risk factors for pancreatic cancer: the Multiethnic Cohort Study. Cancer Causes Control (2007) 1.42
Obesity and overweight in relation to organ-specific cancer mortality in London (UK): findings from the original Whitehall study. Int J Obes (Lond) (2005) 1.36
Adiposity, physical activity, and pancreatic cancer in the National Institutes of Health-AARP Diet and Health Cohort. Am J Epidemiol (2008) 1.35
Anthropometry, physical activity, and the risk of pancreatic cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev (2006) 1.32
Body mass index and cancer: results from the Northern Sweden Health and Disease Cohort. Int J Cancer (2006) 1.31
A prospective study of medical conditions, anthropometry, physical activity, and pancreatic cancer in male smokers (Finland). Cancer Causes Control (2002) 1.28
Dietary factors and risk of pancreatic cancer: results of a Canadian population-based case-control study. Int J Cancer (1990) 1.27
Obesity, physical activity and the risk of pancreatic cancer in a large Japanese cohort. Int J Cancer (2007) 1.25
Body mass index, physical activity and the risk of pancreatic cancer in relation to smoking status and history of diabetes: a large-scale population-based cohort study in Japan--the JPHC study. Cancer Causes Control (2007) 1.22
Nutritional factors and pancreatic cancer: a case-control study from south-west Poland. Int J Cancer (1991) 1.21
Nutritional factors and pancreatic cancer in the francophone community in Montréal, Canada. Int J Cancer (1991) 1.20
Risk factors for pancreatic cancer: an exploratory study. Int J Epidemiol (1993) 1.19
A prospective study of lifestyle factors and the risk of pancreatic cancer in Nord-Trøndelag, Norway. Cancer Causes Control (2000) 1.19
Lifestyle factors and pancreatic cancer risk: a cohort study from the Swedish Twin Registry. Int J Cancer (2002) 1.18
Physical activity, body weight, and pancreatic cancer mortality. Br J Cancer (2003) 1.13
Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans. J Clin Endocrinol Metab (1992) 1.08
Are energy and energy-providing nutrients related to exocrine carcinoma of the pancreas? Int J Cancer (1990) 1.02
Methodologic considerations in the design and conduct of randomized trials: the U.S. Physicians' Health Study. Control Clin Trials (1989) 0.91
Do insulin and the insulin like growth factors (IGFs) stimulate growth of the exocrine pancreas? Gut (1987) 0.90
Insulin secretion as a determinant of pancreatic cancer risk. Med Hypotheses (2001) 0.89
Is pancreatic cancer a preventable disease? JAMA (2001) 0.86
Efficacy of a simple, low-cost educational intervention in improving knowledge about risks and benefits of screening mammography. Mayo Clin Proc (2006) 0.85
Risk factors for pancreatic cancer in the Hawai'i-Los Angeles Multiethnic Cohort Study. Hawaii Med J (2006) 0.78
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37
Finding the missing heritability of complex diseases. Nature (2009) 67.95
Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet (2007) 22.96
Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet (2008) 22.35
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet (2007) 21.18
International network of cancer genome projects. Nature (2010) 20.35
Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01
Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet (2008) 17.65
A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med (2005) 17.32
Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet (2010) 16.96
Identification of ten loci associated with height highlights new biological pathways in human growth. Nat Genet (2008) 16.25
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med (2002) 16.23
Replicating genotype-phenotype associations. Nature (2007) 16.11
A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature (2008) 16.10
Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet (2008) 15.94
Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA (2007) 15.32
A human genome diversity cell line panel. Science (2002) 14.11
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA (2008) 13.35
Body-mass index and mortality among 1.46 million white adults. N Engl J Med (2010) 13.34
Statistics in medicine--reporting of subgroup analyses in clinical trials. N Engl J Med (2007) 12.55
Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet (2009) 12.44
A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol (2003) 12.24
Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA (2005) 12.09
Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med (2003) 11.58
The landscape of cancer genes and mutational processes in breast cancer. Nature (2012) 11.24
Mutational processes molding the genomes of 21 breast cancers. Cell (2012) 11.22
Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet (2012) 11.09
Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA (2011) 11.02
Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem (2003) 10.79
Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA (2003) 10.61
The life history of 21 breast cancers. Cell (2012) 10.59
Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet (2009) 10.34
Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries. Proc Natl Acad Sci U S A (2006) 9.92
Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet (2007) 9.88
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA (2007) 9.68
Managing incidental findings and research results in genomic research involving biobanks and archived data sets. Genet Med (2012) 9.65
Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA (2011) 9.13
Estimation of effect size distribution from genome-wide association studies and implications for future discoveries. Nat Genet (2010) 9.07
Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med (2007) 9.04
Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA (2005) 9.03
Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med (2006) 8.73
Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann Epidemiol (2003) 8.64
Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet (2009) 8.44
Incidental meniscal findings on knee MRI in middle-aged and elderly persons. N Engl J Med (2008) 8.40
A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet (2009) 8.39